How much is Gordian Biotechnology worth in 2026?

Gordian Biotechnology has a current valuation of N/A based on their Later Stage VC round and secondary market data.

How much funding has Gordian Biotechnology raised?

Gordian Biotechnology has raised $60.0M in total funding across 1 funding rounds.

Gordian Biotechnology

Drug DiscoveryWebsite

Gordian Biotechnology valuation and funding history | Last updated: June 1, 2025 | 1 funding rounds

Current Valuation

N/A

As of June 1, 2025

Total Funding Raised

$60.0M

Across 1 round

Last Round

Later Stage VC

$1.5M

Last Funding

Jun 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
April 21, 2020	Seed Round	$1.5M	N/A	-

Valuation Analysis

Current Valuation Metrics

Gordian Biotechnology is currently valued at N/A as of June 1, 2025. The company has raised a total of $60.0M in funding across 1 funding round.

Track Gordian Biotechnology Valuation Updates

Get notified when Gordian Biotechnology raises new funding or valuation changes

Explore More Data

Detailed analysis for Gordian Biotechnology

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Gordian Biotechnology's valuation history, funding rounds, and growth metrics.

No credit card required

What is Gordian Biotechnology Worth in 2026?

Gordian Biotechnology is a leading private company in the Drug Discovery sector. Track Gordian Biotechnology's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Gordian Biotechnology Valuation is Determined

Private company valuations like Gordian Biotechnology's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.